Add BrightSurf on Google Email

Mayo Clinic


Study calls for major reforms in marketing of ephedra

A study found that 41% of web sites selling ephedra products failed to disclose potential adverse effects or contraindications, while 53% did not reveal the dosage of ephedra alkaloids. The authors recommend that makers of dietary supplements containing ephedra should voluntarily disclose pertinent information about the supplements.

SourceMayo Clinic·JournalMayo Clinic Proceedings·DateAug 12, 2003

Mayo Clinic finds key digestive role for 'silent killer'

Researchers found that carbon monoxide helps regulate smooth-muscle contraction in the gastrointestinal tract, enabling precise movement of food through the stomach and bowels. This discovery suggests potential clinical applications for carbon monoxide as a therapeutic agent in treating motility disorders.

SourceMayo Clinic·JournalProceedings of the National Academy of Sciences·DateJun 16, 2003

Mayo Clinic Proceedings study finds little variance in survival

A Mayo Clinic Proceedings study found that overall mortality is not increased among community patients with anorexia nervosa. However, deaths do occur, and further research is needed to define the association of suicide and alcoholism in these patients. The study adds to the knowledge of anorexia nervosa's long-term consequences.

SourceMayo Clinic·JournalMayo Clinic Proceedings·DateMar 11, 2003

Mayo Clinic study shows loss of mental, functional abilities

Researchers discovered that many nonagenarians (people 90-99 years old) are free of Alzheimer's disease or dementia, with some performing in the superior range on cognitive tests. Mild cognitive impairment (MCI) also exists in this age group, but features similar characteristics to those seen in younger individuals.

SourceMayo Clinic·JournalNeurology·DateFeb 10, 2003

New evidence linking smoking and lung cancer in women

A Mayo Clinic study found that adenocarcinoma of the lung is more strongly associated with smoking than previously recognized. Women who smoked a pack of cigarettes a day for 20 to 39 years had a higher risk of developing lung cancer, particularly adenocarcinoma.

SourceMayo Clinic·JournalAmerican Journal of Epidemiology·DateDec 10, 2002

Mayo Clinic physicians look for cause of 'hot tub lung'

Mayo Clinic researchers identified Mycobacterium avium complex as the cause of 'hot tub lung', a previously poorly understood disease. The study found that warm temperatures and inadequate cleaning practices facilitate the growth of MAC in hot tub water, leading to respiratory problems.

SourceMayo Clinic·JournalMayo Clinic Proceedings·DateNov 12, 2002

Study shows first progress in heart-failure survival

A recent study from the Framingham Heart Study has shown a small but significant improvement in heart-failure survival rates since the 1990s. This increase is attributed to the widespread adoption of proven-effective medications such as beta-blockers, ACE inhibitors, and aldosterone antagonists. The findings suggest that treating patie...

SourceMayo Clinic·JournalNew England Journal of Medicine·DateOct 30, 2002

Type A and can’t handle it?

Researchers identified Kir6.2 as a protective mechanism against stress in the heart, which helps maintain equilibrium under peak workloads. The study found that mice lacking this protein experienced severe cardiac distress and died, while those with it survived stress tests.

SourceMayo Clinic·JournalProceedings of the National Academy of Sciences·DateSep 27, 2002

For the first time, drug shows promise to help spit tobacco users quit

A new study found that bupropion significantly improved abstinence rates among participants who used spit tobacco, with 44% quitting after 12 weeks compared to 26% in the placebo group. Additionally, participants taking bupropion gained less weight than those on the placebo, averaging only 1.54 pounds versus 9.7 pounds over the 12-week...

SourceMayo Clinic·JournalNicotine & Tobacco Research·DateSep 3, 2002

Mayo Clinic discovers one more downside to alcoholism

A recent study by Mayo Clinic researchers found that patients with alcoholic-liver disease are at a higher risk of developing confusion and delirium after liver transplant surgery. The study, which included 87 patients, revealed that the length of sobriety before surgery is directly correlated to the severity of these complications.

SourceMayo Clinic·JournalNeurology·DateAug 27, 2002

Mayo Clinic Proceedings features primers on medical genomics

The primer series provides a historical background of genetics and the sequencing of the human genome, as well as principles and methods in molecular biology. The authors highlight the potential benefits of the genomic revolution in understanding diseases such as cancer, heart disease, and Alzheimer's disease.

SourceMayo Clinic·JournalMayo Clinic Proceedings·DateAug 22, 2002

Detection of bioterrorism viruses brought closer to local sites

Mayo Clinic researchers have discovered a way to use autoclave sterilization procedures in laboratory settings to detect and confirm the identity of smallpox virus and other bioterrorism agents. This innovation enables local laboratories to conduct rapid tests, reducing the time needed to respond to potential attacks.

SourceMayo Clinic·JournalMayo Clinic Proceedings·DateJul 9, 2002

Mayo Clinic researchers find useful test for identifying patients

Mayo Clinic researchers have found a renewed use for a test to identify patients at risk of long QT syndrome, a genetic condition that can cause sudden death. The study used epinephrine infusion and electrocardiogram monitoring to detect a specific response in people with long QT syndrome 1, a subtype of the condition.

SourceMayo Clinic·JournalMayo Clinic Proceedings·DateMay 14, 2002

Mayo Clinic researchers develop 'cancer snitch'

Researchers at Mayo Clinic have developed a 'cancer snitch' - a genetically engineered virus that can track the progress of a viral treatment within a tumor. This non-invasive approach provides valuable feedback from within the body, allowing scientists to monitor biological activity and evaluate therapeutic effectiveness.

SourceMayo Clinic·JournalNature Medicine·DateMay 7, 2002